Search - tctmd.com

Displaying 241 - 260 of 883

Sort: Relevancy | Date

Presentation TCT Abstracts Posters 2018

Admission for Decompensated Congestive Heart Failure Within 30 days Prior to Transcatheter Aortic Valve Replacement is Associated with High Rates of Mortality and Readmission Within

Presenter: Tariq Bhat

September 25, 2018

Presentation TCT Abstracts Posters 2018

Short and long term prognostic value of new onset LBBB post Transcatheter Aortic Valve Replacement

Presenter: George M. Yousef

September 25, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Daily News

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Michael O'Riordan

September 20, 2018

News Industry News

Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves

September 18, 2018

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

News Conference News PCR London Valves 2018

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Shelley Wood

September 11, 2018

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Daily News

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Michael O'Riordan

August 08, 2018

News Industry News

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

July 24, 2018

News Daily News

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Shelley Wood

July 23, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Daily News

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Caitlin E. Cox

July 10, 2018

News Industry News

Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR

June 28, 2018

News Conference News The Structural Heart Disease Summit 2018

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

News Conference News The Structural Heart Disease Summit 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

Advertisement

Admission for Decompensated Congestive Heart Failure Within 30 days Prior to Transcatheter Aortic Valve Replacement is Associated with High Rates of Mortality and Readmission Within

Short and long term prognostic value of new onset LBBB post Transcatheter Aortic Valve Replacement

High Mortality but Durable Results With Valve-in-Valve TAVR

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Late Conduction Defects After TAVR: Finding ‘Sweet Spot’ for Early Discharge

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content